LIPOFUNDIN

This brand name is authorized in Brazil, Estonia, Hong Kong SAR China, Lithuania, Poland, Romania, Singapore.

Active ingredients

The drug LIPOFUNDIN contains one active pharmaceutical ingredient (API):

1
UNII 241ATL177A - SOYBEAN OIL
 
Read more about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B05BA02 Fat emulsions B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 520903703153314, 520913110013803
EE Ravimiamet 1032499, 1066755, 1066766, 1066777
HK Department of Health Drug Office 28225, 28226
LT Valstybinė vaistų kontrolės tarnyba 1050878, 1050879, 1050880
PL Rejestru Produktów Leczniczych 100038092, 100038100
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W10045003, W10045004, W10045005, W10045006
SG Health Sciences Authority 05658P, 11673P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈